Joseph Haddad, MD
Urology · Oklahoma City, OKNPI 1609137231
Payments from drug & device makers
Across 48 payments — averaging $59.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$492
- Boston Scientific$450
- GSK$348
- Calyxo, Inc.$263
- Teleflex LLC$236
- Coloplast$167
- plus $904 from 9 others
What the payments were for
- Travel & lodging$39914%
- Food & beverage$2,46186%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $492 |
| Boston Scientific | 4 | $450 |
| GSK | 21 | $348 |
| Calyxo, Inc. | 2 | $263 |
| Teleflex LLC | 2 | $236 |
| Coloplast | 2 | $167 |
| Cook Medical LLC | 2 | $137 |
| Ambu Inc. | 3 | $131 |
| Dendreon Pharmaceuticals LLC | 1 | $123 |
| Endo Pharmaceuticals Inc. | 1 | $122 |
| Laborie Medical Technologies Corp. | 2 | $117 |
| Axonics, Inc. | 1 | $100 |
| Ferring Pharmaceuticals Inc. | 1 | $77 |
| Johnson & Johnson | 1 | $53 |
| Novartis | 1 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$399
- AMS 700$274
- CVAC Aspiration System$263
- UroLift$236
- PROVENGE$123
- XIAFLEX$122
- Lunderquist$119
- Bulkamid$100
How this compares
$2,860 in reported general payments places this provider in the 45th percentile of 145 urology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 77 | $61,253 |
| GemtesaVibegron | 37 | $22,362 |
| Trospium Chloride ErTrospium Chloride | 61 | $18,596 |
| Mirabegron ErMirabegron | 20 | $13,584 |
| Tamsulosin Hcl | 436 | $9,393 |
| Tolterodine Tartrate ErTolterodine Tartrate | 75 | $8,132 |
| Finasteride | 199 | $4,121 |
| Methenamine Hippurate | 25 | $3,498 |
| Estradiol | 30 | $2,053 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 61 | $1,698 |
| Oxybutynin Chloride ErOxybutynin Chloride | 61 | $1,515 |
| Silodosin | 14 | $1,414 |
| Trospium Chloride | 14 | $721 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $301 |
| Cephalexin | 71 | $284 |
Paid to pharmacies, not to this prescriber.
Other urology in Oklahoma City
- Kelly StrattonOklahoma City$1.9M
- Michael CooksonOklahoma City$658K
- Mohammad RamadanOklahoma City$215K
- Basel HassounOklahoma City$46K
- Sanjay PatelOklahoma City$40K
- Ashley BowenOklahoma City$32K
- Sardar Mohammad Khan GalzieOklahoma City$25K
- Dominic FrimbergerOklahoma City$24K
- Johnny HicksonOklahoma City$16K
- Andrew McIntoshOklahoma City$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.